Background The proprotein convertase subtilisin/kexin type 9 (PCSK9) has been confirmed as a major factor regulating cholesterol homeostasis and has low-density lipoprotein receptor (LDLR) impartial effects. infarction. The plasma PCSK9 concentration was measured by ELISA and lipid profiles were measured…